Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria L Garcia

Showing results (71-80 of 122) with videos related to

Pageof 13
Sort By:
Molecular Pharmacology|September 28, 2011
Identification of novel and selective Kv2 channel inhibitorsJames Herrington, Kelli Solly, Kevin S Ratliff, et al.
Molecular Pharmacology|February 15, 2005
Stichodactyla helianthus peptide, a pharmacological tool for studying Kv3.2 channelsLizhen Yan, James Herrington, Ethan Goldberg, et al.
Assay and Drug Development Technologies|August 3, 2004
Functional assay of voltage-gated sodium channels using membrane potential-sensitive dyesJohn P Felix, Brande S Williams, Birgit T Priest, et al.
Colloids and Surfaces. B, Biointerfaces|December 4, 2014
Surface engineering of silica nanoparticles for oral insulin delivery: characterization and cell toxicity studiesTatiana Andreani, Charlene P Kiill, Ana Luiza R de Souza, et al.
Metabolic Brain Disease|November 11, 2011
Contribution of hyperammonemia and inflammatory factors to cognitive impairment in minimal hepatic encephalopathyVicente Felipo, Amparo Urios, Encarna Montesinos, et al.
Biochemistry|November 22, 2007
Characterization of a new class of potent inhibitors of the voltage-gated sodium channel Nav1.7Brande S Williams, John P Felix, Birgit T Priest, et al.
Assay and Drug Development Technologies|August 14, 2012
The inwardly rectifying potassium channel Kir1.1: development of functional assays to identify and characterize channel inhibitorsJohn P Felix, Birgit T Priest, Kelli Solly, et al.
International Journal of Pharmaceutics|August 5, 2014
Preparation and characterization of PEG-coated silica nanoparticles for oral insulin deliveryTatiana Andreani, Ana Luiza R de Souza, Charlene P Kiill, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 7, 2008
Extracellular loop C of NPC1L1 is important for binding to ezetimibeAdam B Weinglass, Martin Kohler, Uwe Schulte, et al.
Nanomaterials (Basel, Switzerland)|February 14, 2020
Metal-Based Nanoparticles as Antimicrobial Agents: An OverviewElena Sánchez-López, Daniela Gomes, Gerard Esteruelas, et al.
Pageof 13

Showing results (71-80 of 122) with videos related to

Sort By:
Pageof 13
Molecular Pharmacology|September 28, 2011
Identification of novel and selective Kv2 channel inhibitorsJames Herrington, Kelli Solly, Kevin S Ratliff, et al.
Molecular Pharmacology|February 15, 2005
Stichodactyla helianthus peptide, a pharmacological tool for studying Kv3.2 channelsLizhen Yan, James Herrington, Ethan Goldberg, et al.
Assay and Drug Development Technologies|August 3, 2004
Functional assay of voltage-gated sodium channels using membrane potential-sensitive dyesJohn P Felix, Brande S Williams, Birgit T Priest, et al.
Colloids and Surfaces. B, Biointerfaces|December 4, 2014
Surface engineering of silica nanoparticles for oral insulin delivery: characterization and cell toxicity studiesTatiana Andreani, Charlene P Kiill, Ana Luiza R de Souza, et al.
Metabolic Brain Disease|November 11, 2011
Contribution of hyperammonemia and inflammatory factors to cognitive impairment in minimal hepatic encephalopathyVicente Felipo, Amparo Urios, Encarna Montesinos, et al.
Biochemistry|November 22, 2007
Characterization of a new class of potent inhibitors of the voltage-gated sodium channel Nav1.7Brande S Williams, John P Felix, Birgit T Priest, et al.
Assay and Drug Development Technologies|August 14, 2012
The inwardly rectifying potassium channel Kir1.1: development of functional assays to identify and characterize channel inhibitorsJohn P Felix, Birgit T Priest, Kelli Solly, et al.
International Journal of Pharmaceutics|August 5, 2014
Preparation and characterization of PEG-coated silica nanoparticles for oral insulin deliveryTatiana Andreani, Ana Luiza R de Souza, Charlene P Kiill, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 7, 2008
Extracellular loop C of NPC1L1 is important for binding to ezetimibeAdam B Weinglass, Martin Kohler, Uwe Schulte, et al.
Nanomaterials (Basel, Switzerland)|February 14, 2020
Metal-Based Nanoparticles as Antimicrobial Agents: An OverviewElena Sánchez-López, Daniela Gomes, Gerard Esteruelas, et al.
Pageof 13